Correlation Between NYSE Composite and Singular Genomics
Can any of the company-specific risk be diversified away by investing in both NYSE Composite and Singular Genomics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NYSE Composite and Singular Genomics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NYSE Composite and Singular Genomics Systems, you can compare the effects of market volatilities on NYSE Composite and Singular Genomics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NYSE Composite with a short position of Singular Genomics. Check out your portfolio center. Please also check ongoing floating volatility patterns of NYSE Composite and Singular Genomics.
Diversification Opportunities for NYSE Composite and Singular Genomics
0.81 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between NYSE and Singular is 0.81. Overlapping area represents the amount of risk that can be diversified away by holding NYSE Composite and Singular Genomics Systems in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Singular Genomics Systems and NYSE Composite is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NYSE Composite are associated (or correlated) with Singular Genomics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Singular Genomics Systems has no effect on the direction of NYSE Composite i.e., NYSE Composite and Singular Genomics go up and down completely randomly.
Pair Corralation between NYSE Composite and Singular Genomics
Assuming the 90 days trading horizon NYSE Composite is expected to generate 3.38 times less return on investment than Singular Genomics. But when comparing it to its historical volatility, NYSE Composite is 13.08 times less risky than Singular Genomics. It trades about 0.11 of its potential returns per unit of risk. Singular Genomics Systems is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest 2,511 in Singular Genomics Systems on August 31, 2024 and sell it today you would lose (321.00) from holding Singular Genomics Systems or give up 12.78% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
NYSE Composite vs. Singular Genomics Systems
Performance |
| Timeline |
NYSE Composite and Singular Genomics Volatility Contrast
Predicted Return Density |
| Returns |
NYSE Composite
Pair trading matchups for NYSE Composite
Singular Genomics Systems
Pair trading matchups for Singular Genomics
Pair Trading with NYSE Composite and Singular Genomics
The main advantage of trading using opposite NYSE Composite and Singular Genomics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NYSE Composite position performs unexpectedly, Singular Genomics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Singular Genomics will offset losses from the drop in Singular Genomics' long position.| NYSE Composite vs. Nextplat Corp | NYSE Composite vs. Qualys Inc | NYSE Composite vs. Cadence Design Systems | NYSE Composite vs. Asure Software |
| Singular Genomics vs. InfuSystems Holdings | Singular Genomics vs. Pro Dex | Singular Genomics vs. LeMaitre Vascular | Singular Genomics vs. Utah Medical Products |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Complementary Tools
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Stocks Directory Find actively traded stocks across global markets | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |